A Montana based molecular diagnostic company, Alercell Inc., is pioneering novel techniques to augment the way leukemia is diagnosed, treated and ultimately prevented.
/PRNewswire/ ALERCELL, INC. announced today that it has introduced a molecular Leukemia diagnostic platform. LENA Molecular Dx Leukemia Platform is a core.
/PRNewswire/ Alercell today announced the opening of Alercell UK LTD. with principal office in central London (UK). Alercell will develop in London its R&D.
/PRNewswire/ ALERCELL, INC. announced today that it has introduced a new Research Use Only (RUO) LENA Q51® Leukemia diagnostic test for commercial sale..